Rowpar Pharmaceuticals Inc., USA
Title: Ubiquitous Xerostomia: Definitions, causes, cases and treatment options
Biography:
James L. Ratcliff is Chairman of the Board and CEO of Rowpar Pharmaceuticals, Inc., Scottsdale, AZ, maker of the ClÅSYS brands of oral care products. In 2017 and 2018, Rowpar was cited by Corporate Livewire as innovative leader in oral care for North America. In 2014, Rowpar received the U.S. Small Business Administration’s Exporter of the Year Award. From 1989 to 2000, He served as senior research scientist, professor and director, Center for the Study of Higher Education at the Pennsylvania State University. From 1979 to 1989, He was professor and program head for higher education at Iowa State University. He is author of 120 articles, books, book chapters, is co-inventor on over 40 patents and patents pending. He is active member of the Arizona Biotechnology Assn., American Academy of Oral and Systemic Health, American Education Research Assn., and the International Association for Dental Research. He holds a Ph.D. in Higher Education from Washington State University, a M.A. in History from Washington State University, and a B.A. from Utah State University.
Xerostomia is ubiquitous. Also, it is defined in a variety of ways. No standard treatment guidelines exist. And there is not apparent cure on the horizon. In this session, several treatment options are reviewed including lifestyle modifications to medications. Drugs, such as pilocarpine and cevimeline provide relief but often come with untoward side effects. Over-the -counter remedies vary in their results, including saliva substitutes and oral lubricants, select toothpastes, alcohol-free mouth rinses, gels and oral sprays, all providing variable results. Because xerostomia is ubiquitous in its manifestations, clinical studies are difficult and necessarily limited in scope.
Clinically, professional and home oral hygiene are key to alleviating discomfort and avoiding complications of xerostomia. Effective treatment options should be viewed as a partnership involving the dental professionals and the patient. Dentists are hygienists are important resources to the patient, providing accurate information about the nature and extent of the condition as well as the treatments available. and instruction regarding home care.
The presentation concludes with a consideration of desired design features for oral care products intended for use with xerostomia conditions. Case studies of patients using CloSYS oral care products show how dental professionals can assist xerostomia patients’ lives by introducing them to safe, effective products that restore comfort and confidence. According to one of these patients, “Dry mouth is the killer of your teeth and your social life. I thank my dentist every time I see her.” Effective, caring, informative treatment can help patients with dry mouth to become parched no more.